Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) learned Monday that the Food and Drug Administration denied approval of the company's fibromyalgia drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE